Serina Therapeutics (NYSE American: SER) stands at a pivotal juncture as it harnesses fresh capital, regulatory momentum, and a sharpened communications strategy to propel its lead program, SER-252, into late-stage clinical testing for advanced Parkinson’s disease. The Alabama-based biotech is betting its…
The global economy, fortified by surprising resilience, now faces a future marked by persistent caution and lurking risks, warns International Monetary Fund Managing Director Kristalina Georgieva. Speaking at a major Washington forum ahead of the IMF’s annual meetings, Georgieva noted that recession…
Tesla (TSLA) has launched new “Standard” versions of its Model 3 sedan and Model Y SUV, aiming to recapture momentum after a year marked by sluggish sales and growing competition in the electric vehicle market. The refreshed lineup is expected to appeal…
Modular Medical (NASDAQ: MODD) is entering a transformational phase with the appointment of David Bosshard as Head of International Operations, marking the company’s most ambitious push toward global expansion and market leadership in diabetes care technology. Bosshard’s proven expertise in scaling European…
Gold’s relentless rally has nudged the precious metal to the brink of $4,000 per ounce, carving out its biggest annual advance since 1979 amid political upheaval and a sharply deteriorating macroeconomic outlook. With the US government mired in a prolonged shutdown and…
Advanced Micro Devices (NasdaqGS: AMD) soared on Monday after signing a blockbuster, multiyear supply agreement with OpenAI that could redefine the balance of power in the red-hot artificial intelligence chip market. Under the terms, OpenAI will purchase up to 6 gigawatts of…
Serina Therapeutics (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, is scripting an uncommon chapter in biotech, bringing together seasoned leadership, investor-grade science, and strategic capital to tackle the field’s toughest clinical problems—all at a…
Amarin Corporation (NASDAQ: AMRN), a company that envisions a world where cardiovascular disease is NOT the leading cause of death worldwide, seemingly presents itself as a deep-value opportunity, trading near its cash value yet is believed to be poised for a turnaround…
Teladoc Health (TDOC) shares are is surging today. On Aug, 14 Teledoc, the global leader in virtual care, announced an acquisition of Telecare, an Australian pioneer in virtual specialist and allied health services—a move celebrated by Wall Street as turbocharging Teladoc’s…
OpenAI, the force behind ChatGPT, has shot to the top of the AI world with a record-breaking secondary share sale that now values the company at $500 billion— vaulting it past SpaceX to become the world’s largest startup. The transaction, finalized this…
